Illumina (NASDAQ:ILMN) Cut to Hold at HSBC
HSBC downgraded shares of Illumina (NASDAQ:ILMN – Free Report) from a buy rating to a hold rating in a research report sent to investors on Friday morning, MarketBeat Ratings reports. The brokerage currently has $100.00 target price on the life sciences company’s stock. A number of other analysts also recently weighed in on ILMN. Robert […]
